Medicines watchdog approves two treatments for patients with spinal muscular atrophyHundreds of children with a rare muscle-wasting disease will be able to receive two drugs that can improve their survival in a move parents hailed as a “lifeline”.The National Institute for Health and Care Excellence (Nice) has published final draft guidance recommending that any patient who would benefit can have…
Source: World news | The Guardian